Literature DB >> 10647715

Problems with and pitfalls of photodynamic therapy.

G A Peyman1, A A Kazi, M Unal, B Khoobehi, S Yoneya, K Mori, D M Moshfeghi.   

Abstract

OBJECTIVE: To delineate the various factors that may influence the outcome of photodynamic therapy of the retina and choroid.
DESIGN: Experimental animal study. ANIMALS: Pigmented and nonpigmented rabbits; rhesus monkeys. INTERVENTION: The hydrophilic photosensitizer, mono-L-aspartyl chlorin e6, which is maximally activated at 664 nm, was studied after intravenous injection into pigmented and nonpigmented rabbits and rhesus monkeys. Laser light was supplied by a red diode laser coupled to a modified slit-lamp biomicroscope and delivered to the ocular fundus after passing through a standard fundus contact lens. Standard photodynamic parameters were used. The effects of fundus pigmentation, intraocular pressure, spot focus and defocus, region of fundus treated, equivalent fluence, and retreatment were observed in the different animal species. MAIN OUTCOME MEASURES: Slit-lamp biomicroscopy, fluorescein angiography, light and transmission electron microscopy.
RESULTS: Fundus pigmentation appeared to be a factor only at the lowest fluence level tested, where only 4 of 12 lesions attempted in pigmented fundi were noted on fluorescein angiography, compared with 12 of 12 lesions in albino rabbits. At normal intraocular pressures and a given fluence, 10 of 10 lesions were fully manifested on fluorescein angiography, compared with 4 of 10 at 30 mmHg and 0 of 10 at pressures sufficient to blanch the optic nerve (>60 mmHg). For laser spots either focused or defocused, there were 6 of 6 lesions that were fully manifested on fluorescein angiography for each of the parameters. Lesions treated in the fovea resulted in larger spots on fluorescein angiography. The fluence of 5 mW for 10 seconds resulted in a larger lesion on angiography than the equivalent fluence of 10 mW for 5 seconds. Areas of retreatment in rabbits demonstrated more thinning of the neurosensory retina and loss of photoreceptor outer segments and nuclei than corresponding areas receiving one treatment.
CONCLUSIONS: Photodynamic therapy results varied, depending on intraocular pressure, region of fundus treated, ocular pigmentation, and the total time of exposure to the photosensitizer. Retreatment resulted in progressive thinning of the neurosensory retina with loss of photoreceptor outer segments and nuclei in the rabbit eye.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10647715     DOI: 10.1016/s0161-6420(99)00012-3

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  9 in total

1.  Concentric retinal pigment epithelium atrophy after a single photodynamic therapy.

Authors:  Joachim Wachtlin; Tim Behme; Heinrich Heimann; Ulrich Kellner; Michael H Foerster
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-05-07       Impact factor: 3.117

2.  Factors influencing the visual acuity of chronic central serous chorioretinopathy.

Authors:  Yun Young Kim; Christina J Flaxel
Journal:  Korean J Ophthalmol       Date:  2011-03-11

3.  Oscillatory photodynamic therapy for choroidal neovascularization and central serous retinopathy; a pilot study.

Authors:  Gholam A Peyman; Michael Tsipursky; Nariman Nassiri; Mandi Conway
Journal:  J Ophthalmic Vis Res       Date:  2011-07

4.  Combined treatment of exudative age related macular degeneration with photodynamic therapy and intravitreal triamcinolone.

Authors:  José M Ruiz-Moreno; Javier A Montero
Journal:  Clin Ophthalmol       Date:  2008-03

5.  Photodynamic Therapy and Intravitreal Bevacizumab with Versus without Triamcinolone for Neovascular Age-related Macular Degeneration; a Randomized Clinical Trial.

Authors:  Niloofar Piri; Hamid Ahmadieh; Ramin Taei; Masoud Soheilian; Reza Karkhaneh; Alireza Lashay; Faegheh Golbafian; Mehdi Yaseri; Mohammad Riazi-Esfahani
Journal:  J Ophthalmic Vis Res       Date:  2014 Oct-Dec

6.  Short-Term Effects of Photodynamic Therapy on Segmentation of Retinal Layers in Central Serous Chorioretinopathy.

Authors:  Shahram Agharokh; Mohammad-Reza Akhlaghi; Farzan Kianersi; Alireza Dehghani; Hamidreza Jahanbani-Ardakani; Seyed-Hossein Abtahi
Journal:  Adv Biomed Res       Date:  2021-11-26

7.  Establishment of monocular-limited photoreceptor degeneration models in rabbits.

Authors:  Hitomi Isago; Eriko Sugano; Namie Murayama; Makoto Tamai; Hiroshi Tomita
Journal:  BMC Ophthalmol       Date:  2013-05-17       Impact factor: 2.209

8.  Triple therapy for neovascular age-related macular degeneration using single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone.

Authors:  P P Yip; C F Woo; H H Y Tang; C K Ho
Journal:  Br J Ophthalmol       Date:  2009-03-08       Impact factor: 4.638

9.  Single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration.

Authors:  Hamid Ahmadieh; Ramin Taei; Masoud Soheilian; Mohammad Riazi-Esfahani; Reza Karkhaneh; Alireza Lashay; Mohsen Azarmina; Mohammad Hossein Dehghan; Siamak Moradian
Journal:  BMC Ophthalmol       Date:  2007-06-07       Impact factor: 2.209

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.